🚀 VC round data is live in beta, check it out!
MatsukiyoCocokara Valuation Multiples
Discover revenue and EBITDA valuation multiples for MatsukiyoCocokara and similar public comparables like BrightSpring Health, Tsuruha Holdings, Droga Raia, Clicks Group and more.
MatsukiyoCocokara Overview
About MatsukiyoCocokara
MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan. The company's main segments are the Matsumotokiyoshi Group Business, focused on stores under the Matsumotokiyoshi brand; the Cocokara Fine Group Business, centered on Cocokara Fine stores; and the Management Support Business, which procures products, oversees group operations, and manages indirect functions such as advertising and promotion. It generates the majority of its revenue from the Matsumotokiyoshi Group Business segment.
Founded
2007
HQ
Employees
27.6K
Website
Sectors
Financials (LTM)
EV
$6B
MatsukiyoCocokara Financials
MatsukiyoCocokara reported last 12-month revenue of $7B and EBITDA of $670M.
In the same LTM period, MatsukiyoCocokara generated $2B in gross profit, $670M in EBITDA, and $360M in net income.
Revenue (LTM)
MatsukiyoCocokara P&L
In the most recent fiscal year, MatsukiyoCocokara reported revenue of $7B and EBITDA of $706M.
MatsukiyoCocokara expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 36% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $670M | XXX | $706M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $360M | XXX | $369M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MatsukiyoCocokara Stock Performance
MatsukiyoCocokara has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
MatsukiyoCocokara's stock price is $16.29.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | 0.1% | XXX | XXX | XXX | $0.93 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMatsukiyoCocokara Valuation Multiples
MatsukiyoCocokara trades at 0.8x EV/Revenue multiple, and 8.8x EV/EBITDA.
EV / Revenue (LTM)
MatsukiyoCocokara Financial Valuation Multiples
As of March 19, 2026, MatsukiyoCocokara has market cap of $6B and EV of $6B.
Equity research analysts estimate MatsukiyoCocokara's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MatsukiyoCocokara has a P/E ratio of 18.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.8x | XXX | 8.3x | XXX | XXX | XXX |
| EV/EBIT | 10.9x | XXX | 10.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | 2.5x | XXX | XXX | XXX |
| P/E | 18.0x | XXX | 17.6x | XXX | XXX | XXX |
| EV/FCF | 22.6x | XXX | 13.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MatsukiyoCocokara Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MatsukiyoCocokara Margins & Growth Rates
MatsukiyoCocokara's revenue in the last 12 month grew by 4%.
MatsukiyoCocokara's revenue per employee in the last FY averaged $0.3M.
MatsukiyoCocokara's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MatsukiyoCocokara's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
MatsukiyoCocokara Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | (5%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MatsukiyoCocokara Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BrightSpring Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Tsuruha Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Clicks Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Yifeng Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MatsukiyoCocokara M&A Activity
MatsukiyoCocokara acquired XXX companies to date.
Last acquisition by MatsukiyoCocokara was on XXXXXXXX, XXXXX. MatsukiyoCocokara acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MatsukiyoCocokara
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMatsukiyoCocokara Investment Activity
MatsukiyoCocokara invested in XXX companies to date.
MatsukiyoCocokara made its latest investment on XXXXXXXX, XXXXX. MatsukiyoCocokara invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MatsukiyoCocokara
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MatsukiyoCocokara
| When was MatsukiyoCocokara founded? | MatsukiyoCocokara was founded in 2007. |
| Where is MatsukiyoCocokara headquartered? | MatsukiyoCocokara is headquartered in Japan. |
| How many employees does MatsukiyoCocokara have? | As of today, MatsukiyoCocokara has over 27K employees. |
| Is MatsukiyoCocokara publicly listed? | Yes, MatsukiyoCocokara is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of MatsukiyoCocokara? | MatsukiyoCocokara trades under 3088 ticker. |
| When did MatsukiyoCocokara go public? | MatsukiyoCocokara went public in 2007. |
| Who are competitors of MatsukiyoCocokara? | MatsukiyoCocokara main competitors are BrightSpring Health, Tsuruha Holdings, Droga Raia, Clicks Group. |
| What is the current market cap of MatsukiyoCocokara? | MatsukiyoCocokara's current market cap is $6B. |
| What is the current revenue of MatsukiyoCocokara? | MatsukiyoCocokara's last 12 months revenue is $7B. |
| What is the current revenue growth of MatsukiyoCocokara? | MatsukiyoCocokara revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of MatsukiyoCocokara? | Current revenue multiple of MatsukiyoCocokara is 0.8x. |
| Is MatsukiyoCocokara profitable? | Yes, MatsukiyoCocokara is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MatsukiyoCocokara? | MatsukiyoCocokara's last 12 months EBITDA is $670M. |
| What is MatsukiyoCocokara's EBITDA margin? | MatsukiyoCocokara's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of MatsukiyoCocokara? | Current EBITDA multiple of MatsukiyoCocokara is 8.8x. |
| What is the current FCF of MatsukiyoCocokara? | MatsukiyoCocokara's last 12 months FCF is $259M. |
| What is MatsukiyoCocokara's FCF margin? | MatsukiyoCocokara's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of MatsukiyoCocokara? | Current FCF multiple of MatsukiyoCocokara is 22.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.